Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

noretreat

Rank: Vice President [?]

Points: 1412 [?]

Votes: 14 Score: 3.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript

in response to

Re: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript

10-41

posted on Jan 07, 2021 04:10PM

Thanks for posting. In my view, Zenith holds much more potential than RVX.

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply